2 results match your criteria: "and Chieti-Pescara Universities[Affiliation]"
Circular RNAs as Potential Biomarkers in Breast Cancer.
Biomedicines
March 2022
Equipe 11 Labellisée Par La Ligue Nationale Contre Le Cancer, Centre de Recherche Des Cordeliers, Inserm U1138, Université de Paris Cité, Sorbonne Université, 75006 Paris, France.
Due to the high heterogeneity and initially asymptomatic nature of breast cancer (BC), the management of this disease depends on imaging together with immunohistochemical and molecular evaluations. These tests allow early detection of BC and patient stratification as they guide clinicians in prognostication and treatment decision-making. Circular RNAs (circRNAs) represent a class of newly identified long non-coding RNAs.
View Article and Find Full Text PDFThe abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
Pharmacol Res
November 2020
CEINGE-Biotecnologie Avanzate s.c.ar.l, Naples 80145, Italy; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples 80131, Italy; Inter-University Center for multifactorial and multi genetic chronic human diseases, "Federico II"- Naples, Tor Vergata- Roma II, and Chieti-Pescara Universities, Italy. Electronic address:
The molecular complexity of human breast cancer (BC) renders the clinical management of the disease challenging. Long non-coding RNAs (lncRNAs) are promising biomarkers for BC patient stratification, early detection, and disease monitoring. Here, we identified the involvement of the long intergenic non-coding RNA 01087 (LINC01087) in breast oncogenesis.
View Article and Find Full Text PDF